Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin effects on Lgi3 in dyslipidemia
NCT03730038Completed
- Sponsor
- Yonsei University
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pitavastatin in dyslipidemia (2 arms), sponsored by Yonsei University. Primary endpoint: Changes in Plasma Lgi3 Level at 12 weeks. Started Feb 2019; status: completed.
02
Drugs
pitavastatin
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT03730038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03730038.